You have 9 free searches left this month | for more free features.

Bicalutamide

Showing 26 - 50 of 240

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Salivary Gland Tumors Trial in Shanghai (Pyrotinib, Bicalutamide, Leuprorelin)

Recruiting
  • Salivary Gland Neoplasms
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Ton
Oct 8, 2021

Prostate Adenocarcinoma, Lower Urinary Tract Symptoms Trial in Australia, New Zealand (Bicalutamide implant)

Unknown status
  • Prostate Adenocarcinoma
  • Lower Urinary Tract Symptoms
  • Bicalutamide implant
  • Wahroonga, New South Wales, Australia
  • +3 more
Jan 13, 2021

Prostatic Tumors Trial in Toronto (hypoxia measurement)

Active, not recruiting
  • Prostatic Neoplasms
  • hypoxia measurement
  • Toronto, Ontario, Canada
    Princess Margaret Hospital
Oct 1, 2021

Prostate Cancer Trial in Chicago (Bicalutamide, Dutasteride, Finasteride)

Active, not recruiting
  • Prostate Cancer
  • Bicalutamide
  • +3 more
  • Chicago, Illinois
    University of Chicago
Sep 30, 2021

Prostate Cancer Trial in Sherbrooke (Radiotherapy 70 Gy, Radiotherapy 76 Gy, Androgen blockade)

Active, not recruiting
  • Prostate Cancer
  • Radiotherapy 70 Gy
  • +2 more
  • Sherbrooke, Quebec, Canada
    Centre de Recherche Clinique du CHUS
May 20, 2022

PSA Level Greater Than Two, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Duarte, South Pasadena (drug, radiation, other)

Active, not recruiting
  • PSA Level Greater Than Two
  • Stage IV Prostate Adenocarcinoma AJCC v7
  • Bicalutamide
  • +4 more
  • Duarte, California
  • +1 more
Apr 4, 2022

COVID-19, SARS-CoV 2 Trial in Baltimore (Bicalutamide 150 Mg Oral Tablet)

Withdrawn
  • COVID-19
  • SARS-CoV 2
  • Bicalutamide 150 Mg Oral Tablet
  • Baltimore, Maryland
    Johns Hopkins Hospital
Mar 2, 2021

Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Stanford (radiation, drug, other)

Active, not recruiting
  • Prostate Adenocarcinoma
  • +4 more
  • Internal Radiation Therapy
  • +7 more
  • Stanford, California
    Stanford University, School of Medicine
Feb 1, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Oct 7, 2022

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)

Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Adenocarcinoma of the Prostate Trial in Sacramento (Stereotactic Radiosurgical Boost, Casodex, Leuprolide)

Recruiting
  • Adenocarcinoma of the Prostate
  • Stereotactic Radiosurgical Boost
  • +2 more
  • Sacramento, California
    UC Davis Sacramento Cancer Center Dept of Radiation Oncology
Sep 24, 2021

Prostate Cancer Trial in United States (GnRH, Bicalutamide, Salvage radiation)

Active, not recruiting
  • Prostate Cancer
  • San Diego, California
  • +7 more
Mar 7, 2022

Prostate Cancer Trial in France (drug, procedure, radiation)

Completed
  • Prostate Cancer
  • bicalutamide
  • +6 more
  • Angers, France
  • +37 more
Jan 17, 2023

Prostate Cancer, Bone Metastases, Prostate Tumors Trial in United States (LHRH agonist/antagonist, Bicalutamide, Radium-223

Terminated
  • Prostate Cancer
  • +2 more
  • LHRH agonist/antagonist
  • +2 more
  • Phoenix, Arizona
  • +11 more
Jul 7, 2022

High-risk Prostate Cancer, Prostate Cancer Trial in Houston (drug, radiation, procedure)

Recruiting
  • High-risk Prostate Cancer
  • Prostate Cancer
  • Houston, Texas
    Houston Methodist Hospital
Apr 5, 2021

Prostate Cancer Trial in Toronto (drug, procedure, radiation)

Completed
  • Prostate Cancer
  • bicalutamide
  • +4 more
  • Toronto, Ontario, Canada
    Toronto Sunnybrook Regional Cancer Centre
Oct 21, 2020

Metastatic Prostate Carcinoma, Metastatic Prostatic Adenocarcinoma, Prostate Carcinoma Metastatic to the Bone Trial in Duarte,

Completed
  • Metastatic Prostate Carcinoma
  • +2 more
  • Robotic Assisted Radical Prostatectomy
  • +4 more
  • Duarte, California
  • +2 more
Apr 7, 2021

Breast Cancer Trial in Groningen (Bicalutamide, FDHT PET)

Completed
  • Breast Cancer
  • Bicalutamide
  • FDHT PET
  • Groningen, Netherlands
    University Medical Center Groningen
Nov 26, 2019

Prostate Cancer Trial in Philadelphia (drug, radiation, genetic)

Active, not recruiting
  • Prostate Cancer
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 7, 2020

Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )

Completed
  • Prostate Cancer
  • bicalutamide
  • +2 more
  • Birmingham, Alabama
  • +239 more
May 23, 2022

Prostate Cancer, Oligometastasis, Oligorecurrence Trial in United States (procedure, radiation, other, drug)

Recruiting
  • Prostate Cancer
  • +4 more
  • PET-directed Local Therapy using Surgery
  • +10 more
  • Long Beach, California
  • +15 more
Jul 29, 2022

Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Metastatic Breast Cancer
  • Angers, France
  • +24 more
Mar 8, 2022

Prostatic Tumors Trial in Korea, Republic of (Leuprorelin, Goserelin, Triptorelin)

Recruiting
  • Prostatic Neoplasms
  • Cheongju, Korea, Republic of
  • +9 more
Jul 28, 2021

Prostate Cancer Trial in Madison (Bicalutamide and CP-675,206 (Tremelimumab), Bicalutamide, CP-675,206 (tremelimumab),

Terminated
  • Prostate Cancer
  • Bicalutamide and CP-675,206 (Tremelimumab)
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Cen
Nov 13, 2019

Prostate Cancer Trial in United States (TAK-700, Bicalutamide)

Active, not recruiting
  • Prostate Cancer
  • Birmingham, Alabama
  • +559 more
Dec 5, 2022